This content is from: Patents

Bass PTAB challenge to Biogen patent fails

The USPTO’s Patent Trial and Appeal Board has refused to institute another inter partes review petition filed by Kyle Bass, this time against a Biogen patent for a method of treating multiple sclerosis

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial